查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655515

體外二氧化碳去除裝置的全球市場

Extracorporeal CO2 Removal Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2030 年全球體外二氧化碳去除裝置市場規模將達 1.519 億美元

2024 年全球體外二氧化碳移除裝置市場規模估計為 1.073 億美元，預計到 2030 年將達到 1.519 億美元，2024-2030 年分析期間內的複合年成長率為 6.0%。體外二氧化碳設備是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 6.6%，達到 8,990 萬美元。在分析期間內，拋棄式部分的複合年成長率預計為 5.4%。

美國市場規模估計為 2,940 萬美元，中國市場預估年複合成長率為 5.5%

預計 2024 年美國體外二氧化碳去除裝置市值將達 2,940 萬美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 2,360 萬美元，2024-2030 年分析期間的複合年成長率為 5.5%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 5.1% 和 5.1%。在歐洲，德國的複合年成長率預計為 4.5%。

全球體外二氧化碳去除設備市場 - 主要趨勢與促進因素摘要

為什麼體外二氧化碳去除裝置對於呼吸照護至關重要？

體外二氧化碳移除（ECCO2R）裝置透過提供傳統機械通氣的微創替代方案，已成為嚴重呼吸系統疾病管理的必需品。 ECCO2R 設備的工作原理是從患者血液中外部去除二氧化碳 (CO2)，為患有慢性阻塞性肺病(COPD)、急性呼吸窘迫症候群(ARDS) 和其他肺部疾病且二氧化碳積聚是一個嚴重問題的患者提供緩解。這些設備對於治療嚴重病例特別有益，無需高壓機械通氣，因為高壓機械通氣可能會導致進一步的肺部損傷。透過降低二氧化碳水平，ECCO2R 設備可以穩定呼吸功能，讓肺部休息和恢復。攜帶式、易於使用版本的開發也擴大了其在加護病房之外的用途，使其成為慢性呼吸道管理的一種有前途的解決方案。

技術進步如何影響 ECCO2R 市場？

醫療技術的不斷進步使得 ECCO2R 設備更有效率、更緊湊，能夠適應不同患者的需求。創新包括整合生物相容性材料以最大限度地減少併發症和感染，以及使用先進的監測系統來確保根據每位患者的具體情況精確去除二氧化碳。醫療保健領域微創方法的趨勢也導致了侵入性較小的 ECCO2R 設備的設計，從而可以更快地進行設定並更容易地整合到現有的呼吸支持系統中。此外，各公司正致力於開發可靈活適應醫院和居家照護環境的可攜式設備，為慢性病管理的新途徑鋪路。這些進步使 ECCO2R 設備成為呼吸系統疾病管理的重要組成部分，改善了患者的治療效果，同時降低了醫療成本。

ECCO2R設備有哪些新的應用與趨勢？

ECCO2R 設備的市場正在超越傳統的醫院環境。隨著全球慢性呼吸系統疾病的增加，ECCO2R 設備擴大被視為長期管理解決方案，尤其是在門診病人和居家醫療環境中。在重症加護環境中，傳統方法無效或有併發症風險的醫療保健專業人員擴大採用 ECCO2R 設備。此外，COVID-19 疫情凸顯了對有效呼吸支援設備的需求，刺激了研究和開發工作，以提高 ECCO2R 的效率和可及性。對病患移動性和舒適度的日益關注也促使製造商進行創新，生產更輕、用途更廣泛的設備，可用於各種護理環境，包括緊急應變單位和野戰醫院。

哪些因素推動了 ECCO2R 市場的成長？

ECCO2R 市場的成長受到多種因素的推動，包括 COPD 和 ARDS 等呼吸系統疾病的盛行率不斷上升，這些疾病需要有效的二氧化碳管理解決方案。 COVID-19 疫情的影響也凸顯了對先進呼吸支援技術的需求，進一步刺激了需求。此外，高度生物相容性和微創 ECCO2R 設備的開發等技術創新正在促進這些系統在各種醫療保健環境中的採用。在患者偏好和降低醫療成本的需求的推動下，攜帶式和居家照護呼吸解決方案的發展進一步推動了市場的成長。醫療保健基礎設施和呼吸設備技術創新的投資不斷增加，尤其是在新興市場，預計將為 ECCO2R 領域提供巨大的成長機會。

部分

產品（體外二氧化碳機器、拋棄式、其他產品）；通路（靜脈、動靜脈）；應用（肺移植橋接、急性呼吸窘迫症候群(ARDS)、慢性阻塞性肺病(COPD)、其他應用）；最終用途（醫院、門診手術中心、診所、其他最終用途）

受訪公司範例（44家值得關注的公司）

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR SPA
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP16374

Global Extracorporeal CO2 Removal Devices Market to Reach US$151.9 Million by 2030

The global market for Extracorporeal CO2 Removal Devices estimated at US$107.3 Million in the year 2024, is expected to reach US$151.9 Million by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by the end of the analysis period. Growth in the Disposables segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.4 Million While China is Forecast to Grow at 5.5% CAGR

The Extracorporeal CO2 Removal Devices market in the U.S. is estimated at US$29.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$23.6 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Extracorporeal CO2 Removal Devices Market - Key Trends & Drivers Summarized

Why Are Extracorporeal CO2 Removal Devices Critical for Respiratory Care?

Extracorporeal CO2 removal (ECCO2R) devices have become vital in the management of severe respiratory conditions, offering a less invasive alternative to traditional ventilation. ECCO2R devices function by removing carbon dioxide (CO2) from the patient’s blood externally, providing relief for patients with chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and other lung disorders where CO2 accumulation is a critical concern. These devices are particularly beneficial in managing severe cases without the need for high-pressure mechanical ventilation, which can cause further lung injury. By reducing CO2 levels, ECCO2R devices help stabilize respiratory functions, allowing the lungs to rest and recover. The development of portable and user-friendly versions of these devices is also expanding their use beyond intensive care units, making them a promising solution for chronic respiratory management.

How Are Technological Advancements Shaping the ECCO2R Market?

With continuous advancements in medical technology, ECCO2R devices are becoming more efficient, compact, and adaptable to various patient needs. Innovations include integrating biocompatible materials that minimize complications and infections, and the use of advanced monitoring systems that ensure precise CO2 removal tailored to each patient’s specific condition. The trend toward minimally invasive approaches in healthcare has also led to the design of ECCO2R devices that are less intrusive, enabling quicker setup and easier integration into existing respiratory support systems. Additionally, companies are focusing on developing portable devices that offer greater flexibility for both in-hospital and home care settings, opening new avenues for chronic condition management. These advancements are making ECCO2R devices a pivotal component in the management of respiratory diseases, enhancing patient outcomes while reducing healthcare costs.

What Are the Emerging Applications and Trends in ECCO2R Devices?

The market for ECCO2R devices is expanding as their applications extend beyond traditional hospital settings. With increasing incidences of chronic respiratory diseases globally, these devices are now being explored for long-term management solutions, especially in outpatient and home-care environments. Medical practitioners are increasingly adopting ECCO2R devices for critical care scenarios where traditional methods might be ineffective or pose risks of complications. Furthermore, the COVID-19 pandemic has highlighted the need for effective respiratory support devices, boosting the research and development efforts towards improving ECCO2R efficiency and accessibility. The growing emphasis on patient mobility and comfort is also pushing manufacturers to innovate, producing lighter and more versatile devices that can be used in diverse care settings, including emergency response units and field hospitals.

What Factors Are Fueling the Growth of the ECCO2R Market?

The growth in the ECCO2R market is driven by several factors, including the increasing prevalence of respiratory diseases such as COPD and ARDS, which demand effective CO2 management solutions. The impact of the COVID-19 pandemic has also underscored the necessity for advanced respiratory support technologies, further stimulating demand. Additionally, technological innovations, such as the development of biocompatible and minimally invasive ECCO2R devices, are enhancing the adoption of these systems in various healthcare settings. The push towards portable and home-care respiratory solutions, fueled by patient preference and the need for healthcare cost reduction, is further accelerating the market’s growth. Rising investments in healthcare infrastructure and respiratory device innovation, particularly in emerging markets, are expected to create significant growth opportunities in the ECCO2R sector.

SCOPE OF STUDY:

The report analyzes the Extracorporeal CO2 Removal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Extracorporeal CO2 Machines, Disposables, Other Products); Access (Venovenous, Arteriovenous); Application (Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), Other Applications); End-Use (Hospitals, Ambulatory Surgery Centers, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR S.P.A
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Extracorporeal CO2 Removal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Respiratory Disorders Fueling Demand for CO2 Removal
    • Growing Adoption of Minimally Invasive Respiratory Support Technologies
    • Expansion of Intensive Care Units and Demand for Advanced Respiratory Equipment
    • Increasing Focus on Reducing Ventilator Dependency in Critical Care
    • Technological Advancements in Extracorporeal Life Support Systems
    • Rising Demand for Portable and User-Friendly CO2 Removal Devices
    • Growth in Awareness of Lung Preservation and Respiratory Support Options
    • Increased Research and Development for Efficient Gas Exchange Technologies
    • Growing Investment in Respiratory Care in Hospitals and Clinics
    • Surge in Use of CO2 Removal in Emergency and Acute Care Settings
    • Expansion of Extracorporeal Therapies in Cardiopulmonary Rehabilitation
    • Rising Demand for CO2 Removal in Pediatric and Neonatal Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Extracorporeal CO2 Removal Devices Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Extracorporeal CO2 Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Venovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Arteriovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bridge To Lung Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION